PRediction of Outcome With ED Intervention for Colles Type Wrist Fractures [PREDICT]
Launched by ROYAL DEVON AND EXETER NHS FOUNDATION TRUST · Feb 28, 2019
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Many thousands of patients attend emergency departments (ED) with displaced (deformed) wrist fractures and undergo closed manipulation under local anaesthetic (MUA) in the ED. Local audit suggests between 25-40% of these manipulated fractures slip back into an unacceptable position (unstable fractures) and require a subsequent open operation to reduce and pin or plate the bone (ORIF). There is some evidence that the degree of initial deformity and other factors might predict instability but this is neither well established nor well researched. Reliably predicting which fractures are likely ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All Adult patients who have under gone a planned ED MUA for a distal radial fracture over a two year period (anonymous data from a previously conducted service evaluation)
- Exclusion Criteria:
- • Smiths' (volarly displaced) fractures
- • Those for whom there is no follow up data in the database eg. Patients who were followed up elsewhere.
- • Open (compound) fractures (need open surgery to wash out and treat)
- • Fractures requiring emergency manipulation due to threatened skin or neurovascular compromise.
About Royal Devon And Exeter Nhs Foundation Trust
The Royal Devon and Exeter NHS Foundation Trust is a leading healthcare organization dedicated to delivering high-quality patient care and advancing medical research. Located in Exeter, the Trust is committed to innovation and excellence in clinical trials, facilitating studies that aim to improve health outcomes and enhance treatment options across various medical disciplines. With a strong emphasis on collaboration, the Trust partners with researchers, healthcare professionals, and patients to foster a research environment that prioritizes safety, ethical standards, and scientific integrity. Through its robust infrastructure and expertise, the Royal Devon and Exeter NHS Foundation Trust plays a vital role in the advancement of evidence-based medicine and the translation of research findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Exeter, Devon, United Kingdom
Patients applied
Trial Officials
Andrew Appelboam
Principal Investigator
Royal Devon and Exeter NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials